Inside Geisinger's new heart failure monitoring program

The latest stories trending on MedCity News.

Editor's Pick

Top Story Geisinger Launches Heart Failure Monitoring Program Using Bodyport's Smart Scale Geisinger is launching a pilot program in partnership with virtual heart failure monitoring startup Bodyport. About 200 of the health system's heart failure patients will be using Bodyport's cardiac scale at home — the scale uses sensors to measure a person's metrics of heart function and body fluid status after they stand on it for about 20 seconds. Sponsored Content Importance of Patient Capital in Life Sciences Presented by TSX VENTURE EXCHANGE (TSXV) TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development purposes. Learn More>>

Featured News

Sage, Biogen Drug Is Now the First Approved Oral Med for Postpartum Depression Sage Therapeutics' Zurzuvae is the biotech's second FDA approved product for postpartum depression, following the 2019 nod for IV-infused Zulresso. But in a blow to the multi-billion dollar partnership between Sage and Biogen, Zurzuvae did not win an additional approval in major depressive disorder. The Importance of Early Bariatric Patient Engagement Engaging with patients in the early stages of their bariatric journey allows providers to ultimately understand and support their patient's unique motivational, emotional, and intellectual drivers. Providers can use these drivers to help empower positive health outcomes. Celebrating Teamwork and Its Impact on Healthcare Excellence Celebrating teamwork is essential for acknowledging its profound impact on healthcare excellence. It is a powerful catalyst that fosters patient-centered care, optimizes resource utilization, nurtures professional growth, and strengthens the healthcare system. Hims & Hers Dips Into Men's Cardiovascular Health Hims & Hers can now provide treatment to men for cardiovascular issues, the company recently announced. This treatment combines sexual health and heart health together in a single pill.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Leslie Orne, CEO of Trinity Life Sciences In this podcast we are joined by Leslie Orne, who just became the new CEO of Trinity Life Sciences. Her company provides consulting services and technology solutions to life sciences firms looking to commercialize their product.  Learn what Orne thinks is in store for AI innovation in the life sciences space. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe